SI-BONE, Inc. Q4 2025 Earnings Call Summary

Achieved record 2025 revenue of $201 million, driven by a 22% increase in U.S. physician adoption and expanded utilization across the sacropelvic platform. Transitioned to a sustainable financial profile, delivering the first full year of positive adjusted EBITDA and reaching positive free cash flow in the fourth quarter. Leveraged a hybrid sales model to drive territory productivity to $2.1 million per manager, an 18% year-over-year increase. Strengthened market leadership in the thoracolumbar spac ...